Bevacizumab Light chain – Cancer Peptides
Light chain of the bevacizumab monoclonal antibody, sold as the antitumour therapeutic Avastin. It prevents vascular endothelial growth factor (VEGF) from binding to VEGF receptors 1 and 2 thus inhibiting angiogenesis in tumours.
Technical specification
| Sequence : | H-STAYLQMNSLR-OH | |
| MW : | 1.282.6 g/mol | |
| Purity : | > 95% | |
| Counter-Ion : | TFA Salts | |
| Delivery format : | Lyophilized |
Price
| Product | Size | Price € | Price $ |
| CRB1001000-0.5 mg | 0.5 mg | 141€ | 170$ |
| CRB1001000-1 mg | 1 mg | 193€ | 232$ |
